National Medical Stores has vaccinated 54,750 people against yellow fever.
The free yellow fever vaccination drive was held at Mayor Gardens in Entebbe from 19th to 30th August 2021.
As part of their annual Corporate Social Responsibility, NMS chose to do a free Yellow Fever Vaccination for people in Entebbe.
This is not the first time NMS is doing a free yellow fever campaign in Uganda.
Early this year, NMS conducted a free yellow fever vaccination in Arua city where over 3000 doses were administered.
What is Yellow Fever?
Yellow fever is an acute viral haemorrhagic disease transmitted by infected mosquitoes. The “yellow” in the name refers to the jaundice that affects some patients.
Symptoms of yellow fever include fever, headache, jaundice, muscle pain, nausea, vomiting and fatigue.
A small proportion of patients who contract the virus develop severe symptoms and approximately half of those die within 7 to 10 days.
The virus is endemic in tropical areas of Africa and Central and South America.
Large epidemics of yellow fever occur when infected people introduce the virus into heavily populated areas with high mosquito density and where most people have little or no immunity, due to lack of vaccination. In these conditions, infected mosquitoes of the Aedes aegypti species transmit the virus from person to person.
Yellow fever is prevented by an extremely effective vaccine, which is safe and affordable. A single dose of yellow fever vaccine is sufficient to grant sustained immunity and life-long protection against yellow fever disease. A booster dose of the vaccine is not needed.
The vaccine provides effective immunity within 10 days for 80-100% of people vaccinated, and within 30 days for more than 99% of people vaccinated.
Good supportive treatment in hospitals improves survival rates. There is currently no specific anti-viral drug for yellow fever.
The Eliminate Yellow fever Epidemics (EYE) Strategy launched in 2017 is an unprecedented initiative. With more than 50 partners involved, the EYE partnership supports 40 at-risk countries in Africa and the Americas to prevent, detect, and respond to yellow fever suspected cases and outbreaks.
The partnership aims at protecting at-risk populations, preventing international spread, and containing outbreaks rapidly. By 2026, it is expected that more than 1 billion people will be protected against the disease.